You are here

Global Health

Primary tabs

The mission of the Global Health Working Group is to explore and improve current and emerging states of health and human security worldwide.

General Topic Tags: 
Problem, Solution, SitRep, or ?: 
Group description: 
This Working Group is focused on exploring current and emerging states of health and human security worldwide.
Group roles and permissions: 
Use default roles and permissions
Group visibility: 
Public - accessible to all site users

Members

Aboubacar Conte admin Albert Gomez Allan Anthony Carrielaj
Chisina Kapungu ChrisAllen Corey Watts CPetry DeannaPolk Elhadj Drame
Gavin Macgregor... Hadiatou Balde hank_test jranck JSole Kathy Gilbeaux
Lisa Stelly Thomas loguest Maeryn Obley mdmcdonald MDMcDonald_me_com Mika Shimizu
mike kraft njchapman Norea Tiaji Salaam-Blyther tnovotny

Email address for group

Effort on Ebola Hurt W.H.O. Chief

NEW YORK TIMES  by Somini Sengupta                                                  Jan. 7, 2015

....Now, Ebola is battering three fragile countries in Africa and with it, the W.H.O.’s standing — in large part, Dr. Chan’s critics say, because she let governments around the world steer the agency to fit their own needs, instead of firmly taking the helm as the world’s doctor in chief.

Diplomacy is an inevitable, even necessary, part of running the world’s main health organization, vital to getting fractious countries to cooperate for the sake of global health, her critics acknowledge.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Ebola deaths top 8,000; exposures trigger health worker evacuations

Ebola: Roundup of recent developments

(Two items. Scroll down for UNMEER report.)

CENTER FOR INFECTIOUSNESS DISEASE AND POLICY   by Lisa Schnirring                              Jan. 5, 2015

As deaths in West Africa's Ebola outbreak officially topped 8,000 over the weekend, leadership of the United Nations Mission for Ebola Emergency Response (UNMEER) changed hands, and Guinea launched a new effort to battle the disease amid continuing reports of community resistance....

In other developments, Guinea's government has announced the launch of a campaign called "zero Ebola in 60 days", UNMEER said today. Guinea's Ebola case counts have been oscillating over the past several months, and in its most recent update, the WHO said it's not clear what the trend is. The first part of Guinea's campaign will start Tuesday, with expert teams traveling to six regions to assess local response efforts and form an action plan for each prefecture that dovetails with Guinea's national action plan.

UNMEER said the campaign's working groups are targeting surveillance, case management, infection control, community engagement and social mobilization, and safe burials.

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Britain says it has strengthened Ebola screening after first case

REUTERS                                                                                            Jan. 6, 2015

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

UN: Ebola kills 8,153 people in West Africa, infects 20,650

ASSOCIATED PRESS                                                                                      Jan. 5, 2015

GENEVA --The World Health Organization says at least 8,153 people have died in the Ebola outbreak in West Africa.

The Geneva-based body said Monday that the total number of confirmed, probable and suspected deaths from the disease comes from 20,656 cases in the three most affected countries — a mortality rate of 39 percent.

The U.N. health agency says 2,915 deaths have been reported from Sierra Leone, 3,471 in Liberia and 1,767 in Guinea.

Read complete story.

http://news.yahoo.com/un-ebola-kills-8-153-people-west-africa-175150599.html

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

J&J, Bavarian Nordic start clinical tests in Ebola vaccine race

REUTERS     by Ben Hirschler                              Jan. 6, 2015
LONDON --Johnson & Johnson has started clinical trials of its experimental Ebola vaccine, which uses a booster from Denmark's Bavarian Nordic, making it the third such shot to enter human testing.

The initiation of the Phase I study in Britain, which had been expected about now, marks further progress in the race to develop a vaccine against a disease that has killed more than 8,000 people in West Africa since last year.

Two other experimental vaccines, one from GlaxoSmithKline and a rival from NewLink and Merck, are already in clinical development. However, the J&J vaccine offers a different approach, since it involves two separate injections.

Read complete story.

http://www.reuters.com/article/2015/01/06/us-health-ebola-vaccine-j-j-idUSKBN0KF0HH20150106

Problem, Solution, SitRep, or ?: 

Ebola’s legacy: After the passing

The virus will have a long-lasting impact on already poor countries

THE ECONOMIST                                                                                                      Jan. 3, 2015
When Ebola was at its worst in west Africa a few months ago, many worried that weak governments in Guinea, Liberia and Sierra Leone might be swept away by riots or the collapse of order as the virus took hold. In fact, the opposite appears to be the case. Governments have tightened their grip and are displaying authoritarian inclinations in ways rarely seen in the three young democracies....

The disease, meanwhile, continues to spread. In the week to December 21st, Guinea experienced its highest incidence of the virus since the outbreak began (see chart). In Liberia dozens of new cases have been reported along the border with Sierra Leone.

Problem, Solution, SitRep, or ?: 

Liberia close to beating Ebola as cases dwindle

THE GUARDIAN  by Lisa O'Caroll                                                                       Jan. 5, 2015

Liberia appears close to beating Ebola, with plans to reopen schools next month after the latest figures showed the infection rate has dwindled to just over four cases a day.


Liberian president, Ellen Johnson Sirleaf, announced that schools would reopen on 2 February. Photograph: John Moore/Getty Images

The US also plans to withdraw about half its 2,400 troops six months after the virus struck, claiming 3,400 lives.

Optimism has been increased by figures issued by the UN Mission for Ebola Emergency Response (Unmeer). They show the country had no confirmed Ebola cases on 31 December and just 91 cases in the past 21 days.

Country / Region Tags: 
General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Ebola: as ZMapp stocks run out doctors turn to alternative treatments

THE GUARDIAN by                                 Jan, 5, 2015
LONDON --Even at the Royal Free hospital in London, the lead UK specialist centre for Ebola, doctors have limited options for treating their patients. In the end, survival may depend more on the strength of an individual’s immune system than anything medical science is currently able to do.

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Travelers from Mali no longer need to go through enhanced Ebola screenings

WASHINGTON POST    by Marc Berman                                                  Jan. 5, 2015

People flying to the United States from Mali will no longer need to go through enhanced Ebola screening at U.S. airports, authorities announced Monday.

An interview with a passenger arriving from a country with known instances of Ebola. (Josh Denmark/U.S. Customs and Border Protection via Reuters)

The change, which goes into effect Tuesday, also means that people flying from Mali no longer have to travel through the five U.S. airports that use the screening methods. Travelers from Mali will continue to be screened before leaving that country, and anyone who flew from Mali to the United States before Tuesday is still supposed to monitor themselves for 21 days and report symptoms.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Merck-NewLink Ebola vaccine trial resumes at lower dose: Geneva hospital

(Two stories. Scroll down.)

REUTERS                                                       Jan. 5, 2015

GENEVA --The clinical trial of an Ebola vaccine developed by Merck and NewLink resumed on Monday at a lower dose after a pause to assess complaints of joint pains in some volunteers, the University of Geneva hospital said.

The Geneva hospital announced on Dec. 11 that its vaccine trial had been suspended as a precautionary measure after four patients complained of joint pains. On Monday, the hospital said 10 of 59 volunteers who received the vaccine had felt pains in their joints "similar to rheumatism" after some two weeks, but these symptoms had disappeared rapidly without any treatment.

Swissmedic, the Swiss regulatory agency, and ethics and safety committees have approved the resumption of the trial at a lower dose, the hospital said in a statement.

Read complete story.

http://www.reuters.com/article/2015/01/05/us-health-ebola-vaccine-idUSKBN0KE0XP20150105
-0-
Read related announcement.

Country / Region Tags: 
General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Pages

howdy folks
Page loaded in 5.524 seconds.